深圳新星(603978) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥501,744,537.85, representing an increase of 87.74% compared to the same period last year[5] - Total revenue for Q1 2024 reached ¥501.74 million, a significant increase of 87.5% compared to ¥267.26 million in Q1 2023[20] - Total operating costs for Q1 2024 were ¥531.49 million, up 85.0% from ¥286.92 million in Q1 2023[20] - Net loss for Q1 2024 was ¥40.36 million, compared to a net loss of ¥13.47 million in Q1 2023, representing a deterioration of 199.5%[21] - Operating profit for Q1 2024 was reported at -¥39.31 million, worsening from -¥14.42 million in Q1 2023[21] - The net profit attributable to shareholders of the listed company was -¥40,161,869.53, indicating a significant loss[5] - The basic and diluted earnings per share were both -¥0.24, reflecting the decline in net profit[5] - The company reported a basic and diluted earnings per share of -¥0.24 for Q1 2024, compared to -¥0.08 in Q1 2023[22] Cash Flow and Liquidity - The net cash flow from operating activities was -¥38,291,878.96, reflecting ongoing cash flow challenges[5] - Cash flow from operating activities in Q1 2024 was ¥455.74 million, an increase from ¥196.21 million in Q1 2023[24] - The net cash flow from operating activities was -38,291,878.96, an improvement from -91,434,066.85 in the previous year[25] - Total cash inflow from financing activities was 320,975,726.10, compared to 230,130,000.00 in the same period last year[26] - The net cash flow from financing activities was 115,801,354.46, down from 139,752,619.33 year-over-year[26] - Cash and cash equivalents at the end of the period totaled 312,271,961.17, a decrease from 355,365,179.01 at the end of the previous year[26] - The company incurred cash outflows of 205,174,371.64 in financing activities, significantly higher than 90,377,380.67 in the prior year[26] - Cash inflow from investment activities was 12,648,328.61, with cash outflows totaling 93,591,363.49, resulting in a net cash flow of -80,943,034.88[25] Assets and Liabilities - Total assets at the end of Q1 2024 amounted to ¥3,756,615,232.14, a 4.90% increase from the end of the previous year[6] - Total assets as of Q1 2024 amounted to ¥3.76 billion, up from ¥3.58 billion in the previous year[18] - Total liabilities increased to ¥2.20 billion in Q1 2024, compared to ¥1.98 billion in Q1 2023[18] - Long-term borrowings rose to ¥611.80 million in Q1 2024, up from ¥471.05 million in Q1 2023, indicating a 29.8% increase[18] - The company reported a total equity attributable to shareholders of ¥1,551,321,048.40, a decrease of 2.64% from the previous year[6] Shareholder Information - The total number of common shareholders at the end of the reporting period is 15,427[12] - The largest shareholder, Chen Xueming, holds 35,111,774 shares, representing 21.16% of total shares[12] Operational Challenges - The company experienced a loss of ¥9,460,700 due to production line shutdowns related to lithium hexafluorophosphate, impacting net profit[9] - The company recorded an asset impairment loss of ¥9,956,800 related to lithium hexafluorophosphate and its raw materials[9] Government Support - The company received government subsidies amounting to ¥1,866,497.90, which were included in the current period's profit[7] Inventory and Receivables - Accounts receivable increased to RMB 432,185,777.23 from RMB 432,080,830.35, indicating a stable collection process[16] - Inventory levels rose to RMB 261,835,142.05 compared to RMB 218,951,046.49 at the end of 2023, reflecting potential growth in sales or production[16] - The total current assets reached RMB 1,791,926,302.74, up from RMB 1,641,426,172.08, showing an increase of approximately 9.2%[16] Investments - The company has a long-term equity investment valued at RMB 41,447,606.98, slightly down from RMB 42,366,474.00[16] - The fixed assets are reported at RMB 1,245,472,611.34, an increase from RMB 1,234,582,337.68, indicating ongoing investment in infrastructure[16] Other Information - The company has not reported any changes in the participation of major shareholders in margin trading or securities lending[14] - There are no significant new strategies or product developments mentioned in the current report[14] - The impact of exchange rate changes on cash and cash equivalents was minimal, recorded at 0.10[26]